Total Funding
2
17
Total FundingPost-IPO Equity raised
Growth Score
2 pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
354800
Cempra develops medicines for the treatment of bacterial infections and chronic illnesses.
Ronald Nardi: SAB member- Daniel Wechsler: President and Chief Executive Officer
About the Company
Cempra seeks to discover and develop well-differentiated medicines that cure bacterial infections and improve the quality of life for those with chronic illnesses. The company balances near-term product development opportunities, including the macrolide CEM-101, while investing in future products from new technologies to derive the next generation
of antibiotics.
Women Founded
